By WILL PERKINS Glasgow News 1 Several new Kentucky laws that affect public schools were the main topic of discussion Monday ...

Obesity — like most other medical conditions — requires an “arsenal” of treatments, rather than a one-size-fits-all approach.

A recent study offers recommendations on how to balance weight loss goals and bone health concerns in weight management ...

May 28, 2025 — Obesity is a global health problem that affects many people. In recent years, very promising anti-obesity drugs have been developed. Despite these successes, there are patients ...

Eating a high-fat diet containing a large amount of oleic acid—a type of fatty acid commonly found in olive oil—could drive obesity more than other types of dietary fats, according to a study ...

This can be explained by the first generation weight loss product that Novo Nordisk had launched, Saxenda (liraglutide), which had been approved by the FDA to treat obesity in 2014. The product ...

Shares in Novo Nordisk were up nearly 12% today – hiking its valuation to more than $280 billion – after it reported new clinical data with one of its obesity drug candidates. The new results ...

Boston Public Radio Podcast Join hosts Jim Braude and Margery Eagan for a smart local conversation with leaders and thinkers shaping Boston and New England. We feature our favorite conversation ...

Lilly and rival Novo Nordisk revolutionized diabetes and obesity treatment over the last few years with GLP-1 medicines that opened up one of the biggest markets the pharmaceutical industry has ever ...